approved the sale of Takuni Land’s shares including approved Takuni Land to purchase the land from a director of the company to be as an access road for the Project (which included in the development cost
business in 1Q2018 decreased from lower selling price of processed food which decreased by 9.70% comparing to 1Q2017. Cost of Sales Cost of sales for 1Q2018 was THB 3,439.11 million, a slight decrease of THB
disposal of assets - 0.0% 174 0.3% (174) (100.0%) Other income(1) 3,419 6.4% 3,282 6.5% 137 4.2% Total revenue 53,444 100.0% 50,307 100.0% 3,137 6.2% Cost of sales of goods 34,980 65.5% 32,724 65.0% 2,257
million) YoY YoY Operating Revenue 251 283 13% 871 1,194 37% Cost of sales (89) (102) 15% (289) (421) 46% Gross Profit 162 181 12% 582 773 33% Other Income 3 4 33% 9 11 22% Selling and distribution expenses
hospital operations 8,880.5 8,073.3 807.2 10.0 Revenue from general patients 5,791.1 5,051.6 739.5 14.6 Revenue from Social Security patients 3,089.4 3,021.7 67.7 2.2 Cost of hospital operations (6,052.2
target group to attract the trials for future sales and cost reductions particularly in redundant procedures to deliver appropriate rate of return on sales. ICUK also continued to bear fruit from
growth through priority channels, strong push of product sampling experiences among the target group to attract the trials for future sales and cost reductions particularly in redundant procedures to
revenue 792 852 978 14.9% 23.5% Cost of sales 326 356 387 8.8% 19.0% Gross profit 466 496 591 19.2% 26.7% EBITDA 320 352 444 26.0% 38.8% Adjusted EBITDA1 324 361 451 25.1% 39.2% EBIT 236 251 333 32.5% 41.3
objective of the termination of this leasehold rights was the ESTATE has intention to develop their new project on this land and to reduce the cost of the Company from recognizing project cost since 2014 when
value of THB 160mn. The acquisition has improved the asset management’s efficiency and reduced cost and risk of depending on the sole major leasers. - On 30 June 2017, Eye On Ads Company Limited, a wholly